Protara Therapeutics, Inc. Foreign Currency Transaction Gain (Loss), Unrealized
Protara Therapeutics, Inc. (TARA) reported Foreign Currency Transaction Gain (Loss), Unrealized of $127.00 thousand for the 12-month period ending 2016-12-31, per its 10-K filed 2019-03-13.
Discontinued › Cash Flow › Operating Activities
us-gaap:ForeignCurrencyTransactionGainLossUnrealized · last filed 2019-03-13
- Protara Therapeutics, Inc. foreign currency transaction gain (loss), unrealized for the quarter ending 2016-12-31 was $0.00.
- Protara Therapeutics, Inc. foreign currency transaction gain (loss), unrealized for the quarter ending 2016-09-30 was $2.00K.
- Protara Therapeutics, Inc. foreign currency transaction gain (loss), unrealized for the quarter ending 2016-06-30 was -$53.00K.
- Protara Therapeutics, Inc. foreign currency transaction gain (loss), unrealized for the quarter ending 2016-03-31 was $178.00K.
- Protara Therapeutics, Inc. foreign currency transaction gain (loss), unrealized for fiscal 2016 was $127.00K.
- Protara Therapeutics, Inc. foreign currency transaction gain (loss), unrealized for fiscal 2015 was -$537.00K.
| Period end | Foreign Currency Transaction Gain (Loss), Unrealized 3 month | Foreign Currency Transaction Gain (Loss), Unrealized 6 month | Foreign Currency Transaction Gain (Loss), Unrealized 9 month | Foreign Currency Transaction Gain (Loss), Unrealized 12 month |
|---|---|---|---|---|
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-13 | $2.00K derived: sum of 2 quarters · filed 2019-03-13 | -$51.00K derived: sum of 3 quarters · filed 2019-03-13 | $127.00K 10-K · filed 2019-03-13 |
| 2016-09-30 | $2.00K 10-Q · filed 2017-11-07 | -$51.00K derived: sum of 2 quarters · filed 2017-11-07 | $127.00K 10-Q · filed 2017-11-07 | $16.00K derived: sum of 4 quarters · filed 2018-03-14 |
| 2016-06-30 | -$53.00K 10-Q · filed 2017-08-07 | $125.00K 10-Q · filed 2017-08-07 | $14.00K derived: sum of 3 quarters · filed 2018-03-14 | -$300.00K derived: sum of 4 quarters · filed 2018-03-14 |
| 2016-03-31 | $178.00K 10-Q · filed 2017-05-10 | $67.00K derived: sum of 2 quarters · filed 2018-03-14 | -$247.00K derived: sum of 3 quarters · filed 2018-03-14 | -$359.00K derived: sum of 4 quarters · filed 2018-03-14 |
| 2015-12-31 | -$111.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-14 | -$425.00K derived: sum of 2 quarters · filed 2018-03-14 | -$537.00K derived: sum of 3 quarters · filed 2018-03-14 | -$537.00K 10-K · filed 2018-03-14 |
| 2015-09-30 | -$314.00K 10-Q · filed 2016-11-07 | -$426.00K derived: sum of 2 quarters · filed 2016-11-07 | -$426.00K 10-Q · filed 2016-11-07 | |
| 2015-06-30 | -$112.00K 10-Q · filed 2016-08-08 | -$112.00K 10-Q · filed 2016-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |